Tag Archives: Amid

Humana warns of ‘uncertainty’ in medical usage amid rising COVID-19 cases

Dive Brief: Non-COVID-19 medical use bounced back faster than expected during the second quarter, Humana executives told investors Wednesday. The insurer was able to post net income of $ 588 million as COVID-19 treatment costs for its members fell faster than anticipated, compared to $ 1.8 billion a year ago as patients deferred care amid the… Read More »

Ireland suspends AstraZeneca vaccine amid blood clot reports

Irish health officials have recommended the temporary suspension of the AstraZeneca vaccine after reports of serious blood clotting after inoculations in Norway ByThe Associated Press March 14, 2021, 10:45 PM • 2 min read Share to FacebookShare to TwitterEmail this article LONDON — Irish health officials on Sunday recommended the temporary suspension of the AstraZeneca… Read More »

Anthem beats in Q3, but profit plummets amid rising costs

Dive Brief: Anthem beat Wall Street’s third-quarter expectations on earnings and reported revenue of $ 31.2 billion, up 16.8% from the year prior, in results released Wednesday morning. Expenses, however, were up more than 22% year over year, leaving profit to plummet roughly 80%. Total medical membership jumped 4%, attributed to increases in Medicare and… Read More »

Gottlieb, Azar push for safe school reopenings amid coronavirus

Two of the nation’s top health experts this week advocated for school reopenings contingent on local coronavirus conditions. Former Food and Drug Administration (FDA) Commissioner Dr. Scott Gottlieb and current Health and Human Services (HHS) Secretary Alex Azar advocated for the reopenings during appearances on CBS’s “Face the Nation.” “We don’t believe there are uniform thresholds for school reopenings,” Azar… Read More »